Navigation Links
Study finds treatment-resistant ringworm prevalent among children in metro elementary schools
Date:4/19/2010

Kansas City, Mo April 19, 2010 Approximately 7 percent of elementary school children across the bi-state, Kansas City metropolitan area are infected with the fungus Trichophyton tonsurans (T. tonsurans), the leading cause of ringworm in the U.S., according to a new study published today in Pediatrics. This is the largest study to date aimed at defining infection prevalence of the scalp fungus in children living in a metropolitan area and has implications for children nationwide.

"The organism T. tonsurans has become the leading cause of scalp infection in the U.S., and we believe it is on the rise in inner city areas," said Susan Abdel-Rahman, Pharm.D., lead study author and professor of pediatrics and pharmacy at Children's Mercy Hospitals and Clinics. "This study supports what I and many of my peers are seeing children with scaly, itchy scalps and hair loss are prevalent in metropolitan areas. If not treated, ringworm can lead to permanent hair loss, which can damage a child's self image. There is also some evidence that it may worsen seemingly unrelated problems such as asthma and allergic rhinitis."

Although its name suggests otherwise, ringworm is caused by a fungus, not a worm. In the past, Microsporum species were the main cause of ringworm, often passed to humans from cats and dogs. However, in recent years, T. tonsurans emerged, which spreads directly between humans, and is more challenging to screen for and treat.

The study of 10,514 children in grades K through 5 across 44 schools found that 6.6 percent of the children evaluated were infected with T. tonsurans. Infection rates varied markedly based on age and race, with African American children at greatest risk. More than 18 percent of the youngest African American children evaluated (kindergarten and first grade) were infected, with that number dropping to 7 percent by the time they reached fifth grade. In contrast, infection rates in Hispanic (1.6 percent) and Caucasian children (1.1 percent) were significantly lower. The reason for the dramatically higher prevalence in African Americans is not clear.

Current treatment regimens for T. tonsurans require a course of oral antifungal medicine typically for six to eight weeks until the symptoms resolve. However, in many of these children the fungus will not be completely eliminated. Consequently, children can still spread the infection to their classmates after being treated. "T. tonsurans has learned how to stay on the host and avoid eradication. This can be very frustrating for children who keep getting re-infected and for their parents who are doing everything they can to prevent this," added Abdel-Rahman. "We have only recently started to appreciate just how many children carry this pathogen so we don't yet know the best way to tackle this problem. However, I do advise parents to limit the sharing of items that come into contact with the scalp such as hats, combs, brushes and pillows. Watch closely for signs of infection such as flaking that looks like dandruff, white patchy scaling, itching, hair thinning or loss, and small pus-filled bumps, especially when your child has come in contact with another infected child. Make an appointment to see your doctor if you suspect that your child is infected and make sure to take the prescribed medicine as directed along with the application of a medicated shampoo two to three times a week."


'/>"/>

Contact: Sherry Gibbs
SDGibbs@cmh.edu
816-346-1340
GolinHarris International
Source:Eurekalert

Related medicine news :

1. Casual Sex Doesnt Cause Emotional Damage: Study
2. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
3. Screening for Spinal Muscular Atrophy Not Cost-Effective: Study
4. New study finds possible source of beta cell destruction that leads to Type 1 diabetes
5. New Study Demonstrates Novel Use of Metabolic Imaging to Locate Sperm in Infertile Men -- Non-Invasive Imaging Procedure May Replace Invasive Techniques such as Testicula
6. Risk of stroke lower for recent Ontario immigrants: study
7. Definitive study confirms chemo benefit in postmenopausal breast cancer
8. Experimental stem cell treatment arrests acute lung injury in mice, study shows
9. Violence is part of the job say nurses as study shows only 1 in 6 incidents are reported
10. Controversial Autism Study Retracted by Medical Journal
11. Study Reveals Impact Of Health Insurance On Hispanics' Attitudes Towards Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... , ... Offering the purest product of its kind, Swissx Labs AG has ... than the market has seen before. Swissx uses proprietary strains of hemp plants grown ... process for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. ...
(Date:4/26/2017)... ... 2017 , ... Journal of Oral Implantology – Tooth loss is ... dental health, including complications with speech, eating, and overcompensation of mouth due to the ... teeth. As the number of tooth replacements increase, it is imperative to design an ...
(Date:4/26/2017)... ... April 26, 2017 , ... The National Business Research ... National Registry of Emergency Medical Technicians and welcomes this organization to the ... Jan G. West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This award ...
(Date:4/26/2017)... ... April 26, 2017 , ... New SUPRO® ... ready-to-drink, high-protein beverages by helping beverage manufacturers more effectively manage protein costs. “Soy ... cost savings as well as more stable pricing over time. Now it’s even ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... an agreement to be the preferred physical therapy provider for Derby City CrossFit, ... to Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces ... Investor Conference 2017 at the Sheraton Hotel in Toronto, ... Officer of the Company is scheduled to present on Tuesday, May ... and the Chairman of the Board, Tony Holler will ... For ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... research provides evidence that an old drug may provide relief ... today that will be presented at the American Academy ... , April 22 to 28, 2017. ... oral drug levodopa has long been considered the gold standard, ... progresses, the effects of the medication can partially wear off ...
Breaking Medicine Technology: